Cardinal Health Benefit from Receivables increased by 8.3% to $13.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 18.8%, from $16.00M to $13.00M. Over 2 years (FY 2021 to FY 2025), Benefit from Receivables shows a downward trend with a -9.7% CAGR.
csco_benefit_from_receivables| Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.00M | $12.00M | $47.00M | $29.00M | $58.00M | $9.00M | $19.00M | $0.00 | $8.00M | $16.00M | $11.00M | $14.00M | $12.00M | $13.00M |
| QoQ Change | — | -25.0% | +291.7% | -38.3% | +100.0% | -84.5% | +111.1% | -100.0% | — | +100.0% | -31.3% | +27.3% | -14.3% | +8.3% |
| YoY Change | — | — | — | +141.7% | — | -69.0% | — | -100.0% | — | +77.8% | -42.1% | — | +50.0% | -18.8% |